Cell surface heparan sulfate proteoglycans - PubMed (original) (raw)

Review

. 1992 May 15;267(14):9451-4.

Affiliations

• PMID: 1577788

Free article

Review

Cell surface heparan sulfate proteoglycans

M Yanagishita et al. J Biol Chem. 1992.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Animal cell mutants defective in heparan sulfate polymerization.
  Esko JD. Esko JD. Adv Exp Med Biol. 1992;313:97-106. doi: 10.1007/978-1-4899-2444-5_10. Adv Exp Med Biol. 1992. PMID: 1442273 Review. No abstract available.
• Heparan sulphate proteoglycans: molecular organisation of membrane--associated species and an approach to polysaccharide sequence analysis.
  Gallagher JT, Turnbull JE, Lyon M. Gallagher JT, et al. Adv Exp Med Biol. 1992;313:49-57. doi: 10.1007/978-1-4899-2444-5_5. Adv Exp Med Biol. 1992. PMID: 1442269 Review. No abstract available.
• The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.
  Iozzo RV, Cohen IR, Grässel S, Murdoch AD. Iozzo RV, et al. Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):625-39. doi: 10.1042/bj3020625. Biochem J. 1994. PMID: 7945186 Free PMC article. Review. No abstract available.
• Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism.
  Williams KJ, Fuki IV. Williams KJ, et al. Curr Opin Lipidol. 1997 Oct;8(5):253-62. doi: 10.1097/00041433-199710000-00003. Curr Opin Lipidol. 1997. PMID: 9335948 Review.
• Heparan sulphate in the binding and activation of basic fibroblast growth factor.
  Gallagher JT, Turnbull JE. Gallagher JT, et al. Glycobiology. 1992 Dec;2(6):523-8. doi: 10.1093/glycob/2.6.523. Glycobiology. 1992. PMID: 1472758 Review.

Cited by

• Thrombin-derived C-terminal peptides bind and form aggregates with sulfated glycosaminoglycans.
  Petruk G, Petrlova J, Samsudin F, Bond PJ, Schmidtchen A. Petruk G, et al. Heliyon. 2024 Aug 2;10(16):e35703. doi: 10.1016/j.heliyon.2024.e35703. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39229523 Free PMC article.
• Role of Nanoparticle-Conjugates and Nanotheranostics in Abrogating Oxidative Stress and Ameliorating Neuroinflammation.
  Patel TA, Kevadiya BD, Bajwa N, Singh PA, Zheng H, Kirabo A, Li YL, Patel KP. Patel TA, et al. Antioxidants (Basel). 2023 Oct 18;12(10):1877. doi: 10.3390/antiox12101877. Antioxidants (Basel). 2023. PMID: 37891956 Free PMC article. Review.
• Maternal plasma syndecan-1: a biomarker for fetal growth restriction.
  Juusela A, Jung E, Gallo DM, Bosco M, Suksai M, Diaz-Primera R, Tarca AL, Than NG, Gotsch F, Romero R, Chaiworapongsa T. Juusela A, et al. J Matern Fetal Neonatal Med. 2023 Dec;36(1):2150074. doi: 10.1080/14767058.2022.2150074. J Matern Fetal Neonatal Med. 2023. PMID: 36597808
• Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells.
  Rattila S, Kleefeldt F, Ballesteros A, Beltrame JS, L Ribeiro M, Ergün S, Dveksler G. Rattila S, et al. Reproduction. 2020 Nov;160(5):737-750. doi: 10.1530/REP-20-0169. Reproduction. 2020. PMID: 33065549 Free PMC article.
• Emerging treatments for progressive myoclonus epilepsies.
  Riva A, Guglielmo A, Balagura G, Marchese F, Amadori E, Iacomino M, Minassian BA, Zara F, Striano P. Riva A, et al. Expert Rev Neurother. 2020 Apr;20(4):341-350. doi: 10.1080/14737175.2020.1741350. Epub 2020 Mar 17. Expert Rev Neurother. 2020. PMID: 32153206 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations